NCT06820125Recruiting
Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation
Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation in Patients with Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 11 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The first aim of this project is to investigate the effects of different high-tech neurorehabilitation interventions (cognitive, motor, and combined cognitive-motor) on both cognitive and motor disability outcomes in people with multiple sclerosis (MS). The second aim is to identify the cognitive and motor profiles of MS patients who benefit the most from either the combined cognitive-motor rehabilitation intervention or the isolated cognitive or motor treatments.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- First submitted
- 24 Jan 2025
- Start date
- 5 Jul 2023
- Primary completion date
- 5 Jul 2023
- Lead sponsor
- Universita di Verona
- Diseases
- Multiple sclerosis
- NCT number
- NCT06820125
What you commit to
- Study type: Interventional
- Planned participants: 48
- From 5 Jul 2023 to the primary completion date, 5 Jul 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- any type of rehabilitation intervention in the month prior to recruitment
- pharmacological therapy not well defined and/or changed during the study
- lower limb botulinum toxin injections within the previous 12 weeks
Other illness
- presence of other neurological disorders than MS,
- major psychiatric disorders,
Other
- high levels of anxiety and/or depression (score\>20 for Depression scale and up to 14 for Anxiety scale on Italian adaptation of the Depression, Anxiety and Stress Scale (DASS-21),
- substance abuse,
- presence of paroxysmal vertigo
Who the study is looking for
- presence of mild (one or two neuropsychological tests below the cut-off score, 5th percentile) or severe (more than two neuropsychological tests below the cut-off score, 5th percentile) cognitive impairment,
- mild to moderate walking disability with Expanded Disability Status Scale (EDSS) between 3 and 6,
- no relapse or associated steroid use in the past three months,
- adequate visual and auditory capacity to operate computer software.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sezione medicina fisica e riabilitativa dipartimento di neuroscienze Coordinator of this site? Confirm its status | Verona | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.